CHAD MARSH: Open Payments
NPI 1891065207 · FAIRMONT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 33 payments from 9 companies in 2025. Trend: 2023 $1,004 · 2024 $705 · 2025 $821
Food & beverage: $821
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $303 |
| Novo Nordisk Inc | 15 | $285 |
| Exact Sciences Corporation | 5 | $81 |
| PFIZER INC. | 2 | $44 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Abbott Laboratories | 1 | $22 |
| Viatris Specialty LLC | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: BRILINTA, Wegovy, Cologuard Collection Kit, FARXIGA, Ozempic, Rybelsus, NEXLETOL, PAXLOVID.
Industry payments across WV — which companies pay providers there.
